Skip to content
Genialis Logo Genialis Logo Genialis Logo
  • Solutions
    • Therapeutic Intelligence & Biomarker Discovery
    • Genialis™ krasID
    • Genialis™ Expressions
  • Approach
    • Genialis™ Supermodel
    • Genialis ResponderID™
    • Why RNA?
  • Case Studies
  • About Us
    • Meet Our Team
    • Careers
    • Compliance
  • Media
    • News and Events
    • Scientific Publications
    • Press Releases
    • TPM Podcast
  • Get in Touch
  • Solutions
    • Therapeutic Intelligence & Biomarker Discovery
    • Genialis™ krasID
    • Genialis™ Expressions
  • Approach
    • Genialis™ Supermodel
    • Genialis ResponderID™
    • Why RNA?
  • Case Studies
  • About Us
    • Meet Our Team
    • Careers
    • Compliance
  • Media
    • News and Events
    • Scientific Publications
    • Press Releases
    • TPM Podcast
  • Get in Touch

Talking Precision Medicine Podcast

Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.

Open Media Kit
  • Talking Precision Medicine podcast Episode 38. Zola-007: Giving T-cells the license to kill, guest: Art Krieg, Zola Therapeutics
    August 29, 2024

    Zola-007: Giving T-cells the license to kill | TPM podcast #38

  • Talking Precision Medicine podcast Episode 37. Cell therapy for T-cell malignancies—the science and business of developing curative medicines for patients in need, guest: Sarah Hein, March Biosciences
    July 22, 2024

    Cell therapy for T-cell malignancies—the science and business of developing curative medicines for patients in need | TPM podcast #37

  • Talking Precision Medicine podcast Episode 36. Tackling healthcare disparities and bridging the digital divide: it doesn’t have to be so hard, guests: Jennifer Goldsack and Yashoda Sharma, Digital Medicine Society
    May 24, 2024

    Tackling healthcare disparities and bridging the digital divide: it doesn’t have to be so hard | TPM podcast #36

  • Talking Precision Medicine podcast Episode 35. The Science and Art of De-risking Cancer Drug Development guest: Carolina Haefliger, Debiopharm
    April 12, 2024

    The Science and Art of De-risking Cancer Drug Development | TPM podcast #35

  • Talking Precision Medicine podcast Episode 34. Professional grade software - a key ingredient in cutting edge biomedical discovery, guest: Adam Stasio, SciMed
    December 14, 2023

    Professional grade software — a key ingredient in cutting edge biomedical discovery | TPM podcast #34

  • Talking Precision Medicine podcast Episode 33. New Medicines from Evolutionary Pathways: Using Comparative Genomics to Treat Human Disease, guest: Ashley Zehnder, Fauna Bio
    October 27, 2023

    New Medicines from Evolutionary Pathways: Using Comparative Genomics to Treat Human Disease | TPM podcast #33

  • TPM podcast Episode 32 with Ajay Gopal: To achieve personalized medicine, start by getting the dose right
    August 2, 2023

    To achieve personalized medicine, start by getting the dose right | TPM podcast #32

  • Talking Precision Medicine podcast Episode 32. AI and Ethics in Healthtech: Who is Innovating Most? Guest: Amy MacDougall (Hurwitz), BCG
    June 29, 2023

    AI and Ethics in Healthtech: Who is Innovating Most? | Podcast #31

  • Talking Precision Medicine podcast Episode 30. People first: building a company that inspires impactful work, guests: Tjaša Krisper Kutin, Luka Ausec and Miha Štajdohar, Genialis
    May 31, 2023

    People first: building a company that inspires impactful work with Genialis leadership team | Podcast #30

Previous123456Next

Genialis, Inc.

68 Harrison Ave #605
PMB 29417
Boston, MA 02111

Get in touch

+1 617 237 0085 (US)
+386 59 054 580 (Slo)
info @ genialis.com
biomarkers @ genialis.com
Genialis LinkedIn

Site map

  • Therapeutic Intelligence & Biomarker Discovery
  • Genialis™ krasID
  • Genialis™ Expressions
  • Why RNA
  • Genialis ResponderID™
  • Genialis™ Supermodel
  • Case Studies
  • Meet Our Team
  • Careers
  • Compliance

Media

  • News and Events
  • Scientific Publications
  • Press Releases
  • Talking Precision Medicine Podcast
Subscribe to our newsletter

Genialis is a founding member of the Alliance for AI in Healthcare

Alliance for Artificial Intelligence in Healthcare AAIH logo
  • Privacy Policy
  • Terms of Service
  • Genialis d.o.o.
  • Privacy Policy
  • Terms of Service
  • Genialis d.o.o.

Copyright © Genialis, Inc.

Page load link

Media Kit

Boilerplate

Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are revolutionizing precision oncology with RNA and AI.

Links & Downloads

Genialis Logo
Leadership Headshots
Talking Precision Medicine Info Sheet
Leadership Team
linkedin.com/company/genialis

Media Contact

Andrea Vuturo
Vuturo Group for Genialis
andrea@vuturo.com
+1-415-689-8414

Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025.  Read the press release →               

Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025.  Read the press release →               Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025.  Read the press release →               

Subscribe to Genialis updates and information

Thanks for subscribing!
There was an error trying to subscribe. Please try again later.
This website uses cookies and third party services. Read More Accept Reject